Oaktree Acquisition III Life Sciences EBIT 2025-2024 | OACC

Oaktree Acquisition III Life Sciences ebit from 2025 to 2024. Ebit can be defined as earnings before interest and taxes.
Oaktree Acquisition III Life Sciences Annual EBIT
(Millions of US $)
Oaktree Acquisition III Life Sciences Quarterly EBIT
(Millions of US $)
2024-09-30
Sector Industry Market Cap Revenue
$0.234B $0.000B
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
Stock Name Country Market Cap PE Ratio
Flowco Holdings (FLOC) United States $1.930B 0.00
Aduro Clean Technologies (ADUR) Canada $0.157B 0.00
Range Capital Acquisition (RANG) United States $0.142B 0.00
Tavia Acquisition (TAVI) $0.141B 0.00
YSX Tech (YSXT) China $0.103B 0.00
Leishen Energy Holding (LSE) China $0.099B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Youxin Technology (YAAS) China $0.057B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.047B 0.00
Sky Quarry (SKYQ) United States $0.015B 0.00
PicoCELA (PCLA) Japan $0.012B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.010B 0.00